| __timestamp | Insmed Incorporated | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 33534999 | 9216000000 |
| Thursday, January 1, 2015 | 1982000 | 8296000000 |
| Friday, January 1, 2016 | 2438000 | 10044000000 |
| Sunday, January 1, 2017 | 2901000 | 11560000000 |
| Monday, January 1, 2018 | 2423000 | 10558000000 |
| Tuesday, January 1, 2019 | 24212000 | 9351000000 |
| Wednesday, January 1, 2020 | 39872000 | 8933000000 |
| Friday, January 1, 2021 | 44152000 | 8284000000 |
| Saturday, January 1, 2022 | 55126000 | 7952000000 |
| Sunday, January 1, 2023 | 65573000 | 8200000000 |
| Monday, January 1, 2024 | 8480000000 |
Unveiling the hidden dimensions of data
In the ever-evolving pharmaceutical industry, understanding cost structures is crucial. Teva Pharmaceutical Industries Limited, a global leader, and Insmed Incorporated, a rising star, offer a fascinating comparison. From 2014 to 2023, Teva's cost of revenue consistently dwarfed Insmed's, reflecting its expansive operations. In 2023, Teva's cost of revenue was approximately 8.2 billion, a slight decrease from its peak in 2017. Meanwhile, Insmed's cost of revenue grew significantly, reaching 65.6 million in 2023, marking a 95% increase from 2014. This growth underscores Insmed's aggressive expansion and investment in innovation. Despite the vast difference in scale, both companies demonstrate strategic financial management, adapting to market demands and economic challenges. This comparison not only highlights the diverse strategies within the pharmaceutical sector but also offers insights into how companies navigate financial landscapes to maintain competitiveness.
Cost of Revenue: Key Insights for Regeneron Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Limited
Cost of Revenue: Key Insights for Teva Pharmaceutical Industries Limited and Dr. Reddy's Laboratories Limited
Comparing Cost of Revenue Efficiency: Teva Pharmaceutical Industries Limited vs Bio-Techne Corporation
Cost Insights: Breaking Down Teva Pharmaceutical Industries Limited and Telix Pharmaceuticals Limited's Expenses
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Xenon Pharmaceuticals Inc.
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Bausch Health Companies Inc.
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Mesoblast Limited
Cost of Revenue Trends: Biogen Inc. vs Insmed Incorporated
Insmed Incorporated vs Exelixis, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Insmed Incorporated and Telix Pharmaceuticals Limited
Cost of Revenue: Key Insights for Insmed Incorporated and Ionis Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Insmed Incorporated vs Bausch Health Companies Inc.